Purton Louise E, Scadden David T
Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA 02114, USA.
Cell Stem Cell. 2007 Sep 13;1(3):263-70. doi: 10.1016/j.stem.2007.08.016.
Hematopoiesis arguably provides the most well-defined role of stem cells in tissue development, maintenance, and repair, largely because of the experimental methods developed over decades of investigation. Assays of hematopoietic stem and progenitor cell potential were developed in the late 1950s-1960s with the first reports of in vivo transplantation into lethally irradiated recipients (Ford et al., 1956; McCulloch and Till, 1960) and clonal growth of hematopoietic bone marrow cells in vitro (Bradley and Metcalf, 1966). These two major assays have undergone substantial refinement but remain the foundation for defining hematopoietic stem cell biology. Here, we provide a brief overview of methods commonly used to analyze hematopoietic stem and progenitor cell content in mice, discuss the limitations of these assays, and provide an in-depth review of the limiting dilution assay (Szilvassy et al., 1990), the best single assay for quantitating HSC content.
造血作用可以说是干细胞在组织发育、维持和修复中最明确的作用,这很大程度上归功于几十年来研究所开发的实验方法。造血干细胞和祖细胞潜能的检测方法是在20世纪50年代末至60年代开发出来的,当时首次报道了将其体内移植到接受致死性照射的受体中(福特等人,1956年;麦卡洛和蒂尔,1960年),以及造血骨髓细胞在体外的克隆生长(布拉德利和梅特卡夫,1966年)。这两种主要检测方法已经有了很大改进,但仍然是定义造血干细胞生物学的基础。在这里,我们简要概述了常用于分析小鼠造血干细胞和祖细胞含量的方法,讨论了这些检测方法的局限性,并对极限稀释分析(西尔瓦西等人,1990年)进行了深入综述,这是定量造血干细胞含量的最佳单一检测方法。